1
|
Caggiano C, Morselli M, Qian X, Celona B, Thompson M, Wani S, Tosevska A, Taraszka K, Heuer G, Ngo S, Steyn F, Nestor P, Wallace L, McCombe P, Heggie S, Thorpe K, McElligott C, English G, Henders A, Henderson R, Lomen-Hoerth C, Wray N, McRae A, Pellegrini M, Garton F, Zaitlen N. Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis. medRxiv 2024:2024.04.08.24305503. [PMID: 38645132 PMCID: PMC11030489 DOI: 10.1101/2024.04.08.24305503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/23/2024]
Abstract
Cell-free DNA (cfDNA) is increasingly recognized as a promising biomarker candidate for disease monitoring. However, its utility in neurodegenerative diseases, like amyotrophic lateral sclerosis (ALS), remains underexplored. Existing biomarker discovery approaches are tailored to a specific disease context or are too expensive to be clinically practical. Here, we address these challenges through a new approach combining advances in molecular and computational technologies. First, we develop statistical tools to select tissue-informative DNA methylation sites relevant to a disease process of interest. We then employ a capture protocol to select these sites and perform targeted methylation sequencing. Multi-modal information about the DNA methylation patterns are then utilized in machine learning algorithms trained to predict disease status and disease progression. We applied our method to two independent cohorts of ALS patients and controls (n=192). Overall, we found that the targeted sites accurately predicted ALS status and replicated between cohorts. Additionally, we identified epigenetic features associated with ALS phenotypes, including disease severity. These findings highlight the potential of cfDNA as a non-invasive biomarker for ALS.
Collapse
Affiliation(s)
- C Caggiano
- Department of Neurology, UCLA, Los Angeles, California
- Institute of Genomic Health, Icahn School of Medicine at Mt Sinai, New York, New York
| | - M Morselli
- Department of Molecular, Cell, and Developmental Biology, UCLA; Los Angeles, California
- Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy
| | - X Qian
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - B Celona
- Cardiovascular Research Institute, UCSF, San Francisco, California
| | - M Thompson
- Department of Neurology, UCLA, Los Angeles, California
- Systems and Synthetic Biology, Centre for Genomic Regulation, Barcelona, Spain
| | - S Wani
- Cardiovascular Research Institute, UCSF, San Francisco, California
| | - A Tosevska
- Department of Molecular, Cell, and Developmental Biology, UCLA; Los Angeles, California
- Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria
| | - K Taraszka
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
| | - G Heuer
- Computational and Systems Biology Interdepartmental Program, UCLA, Los Angeles, California
| | - S Ngo
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia
- Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - F Steyn
- School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Australia
| | - P Nestor
- Queensland Brain Institute, Unviversity of Queensland, Brisbane, Australia
- Mater Public Hospital, Brisbane, Australia
| | - L Wallace
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - P McCombe
- Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - S Heggie
- Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - K Thorpe
- Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | | | - G English
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - A Henders
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - R Henderson
- Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - C Lomen-Hoerth
- Department of Neurology, UCSF, San Francisco, California
| | - N Wray
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - A McRae
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - M Pellegrini
- Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy
| | - F Garton
- Institute for Molecular Biology, University of Queensland, Brisbane, Australia
| | - N Zaitlen
- Department of Neurology, UCLA, Los Angeles, California
- Department of Human Genetics, University of California Los Angeles, Los Angeles, California
| |
Collapse
|
2
|
Ali J, Thompson M, Mackenzie C. Assessing the frequency and types of errors involved in the use of a modified intravenous N-acetylcysteine protocol for acetaminophen overdose. CAN J EMERG MED 2024; 26:174-178. [PMID: 38340270 DOI: 10.1007/s43678-023-00641-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 12/27/2023] [Indexed: 02/12/2024]
Abstract
BACKGROUND Acetaminophen overdose is a leading cause of acute liver failure in developing countries. N-acetylcysteine (NAC) is a highly effective antidote for acetaminophen hepatotoxicity, typically initiated in the emergency department. Due to a known high rate of errors with the standard three-bag IV NAC protocol, in 2019, the Ontario Poison Center changed to a modified 3% IV NAC one-bag protocol. This study was undertaken to determine the frequency and types of errors associated with the use of this protocol. METHODS Data were gathered via chart review of Ontario Poison Centre electronic medical record cases identified as receiving IV NAC for acetaminophen overdose between August 1 and September 30, 2022. 218 total charts were identified, and 188 were deemed eligible based on inclusion and exclusion criteria. RESULTS Errors were identified in 25% of charts, consisting of dosing errors in 11.7%, stopping errors in 9.0%, initiation errors in 3.7%, and interruptions in therapy in 3.2%. Dosing errors were the most common type of error (44.4%), with overdoses occurring three times more than underdoses. Errors were identified at 39% of geographic locations in the charts reviewed, with similar frequency in Ontario, Manitoba, and Nunavut. Clinical outcomes were similar in charts with and without errors. INTERPRETATION The rate of errors identified with this 3% IV NAC one-bag protocol is lower than reported for the standard three-bag protocol, but remains high due to dosing errors. Previously reported issues with prolonged interruptions in therapy with the standard three-bag protocol were low with the current 3% one-bag protocol. Although severe outcomes are rare, IV NAC overdose can be fatal. Identifying local factors in emergency departments that can contribute to administration errors (i.e., dose calculation, pump programming issues) can enhance the safety of this important antidote.
Collapse
Affiliation(s)
- J Ali
- Department of Medicine, Western University, London, ON, Canada
| | - M Thompson
- Ontario Poison Centre, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada
- Division of Emergency Medicine, St. Michael's Hospital, Toronto, ON, Canada
| | - Connie Mackenzie
- Ontario Poison Centre, Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada.
- Divisions of Clinical Pharmacology and Toxicology/Respirology, Western University, London, ON, Canada.
| |
Collapse
|
3
|
Pawlak SA, Thompson M, Boyd-Rogers C, Hambright S. Letter to the editor: Description of a novel multidisciplinary maternal substance use disorder clinic. Gen Hosp Psychiatry 2023:S0163-8343(23)00051-8. [PMID: 37037700 DOI: 10.1016/j.genhosppsych.2023.03.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Revised: 03/25/2023] [Accepted: 03/29/2023] [Indexed: 04/12/2023]
Affiliation(s)
- S A Pawlak
- Department of Psychiatry, University of Iowa Hospitals & Clinics, 200 Hawkins Drive, Iowa City, IA, United States.
| | - M Thompson
- Department of Obstetrics & Gynecology, University of Minnesota, 5-140 Weaver-Densford Hall, 308 Harvard St. S.E., Minneapolis, MN 55455, United States.
| | - C Boyd-Rogers
- Department of Psychological and Brain Sciences, University of Iowa, G60 Psychological and Brain Sciences Bldg., 340 Iowa Avenue, Iowa City, IA 52242, United States.
| | - S Hambright
- Department of Obstetrics & Gynecology, University of Iowa Hospitals & Clinics, 200 Hawkins Drive, 31131 PFP, Iowa City, IA, United States.
| |
Collapse
|
4
|
Yang W, Hosgood G, Foster S, Langner K, Hayward D, Thompson M. Assessment of a compounded synthetic adrenocorticotropic hormone product in 17 healthy dogs. Aust Vet J 2023; 101:127-132. [PMID: 36594371 DOI: 10.1111/avj.13225] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 12/05/2022] [Accepted: 12/12/2022] [Indexed: 01/04/2023]
Abstract
OBJECTIVES Synthetic adrenocorticotropic hormone or tetracosactide is routinely used in the diagnosis of hypoadrenocorticism and frequently in the diagnosis and treatment of hyperadrenocorticism. There have been repeated shortages of tetracosactide in recent years in Australia. This study investigated the agreement of serum cortisol after a compounded tetracosactide (Bova Aus), compared to commercial tetracosactide (Synacthen®) in healthy dogs. METHODS Prospective crossover study using 20 dogs. Ten dogs received 5 μg/kg Synacthen® on day 1 and 5 μg/kg compounded tetracosactide on Day 2. The other 10 dogs received the reverse order. Cortisol concentrations in each dog 1 h after injection were compared for agreement, which was defined as the limits of agreement of the Bland-Altman ratio to be within a range of 0.8-1.25. Passing-Bablok regression analysis examined for constant and proportional biases. RESULTS Three dogs were excluded with post-stimulation serum cortisol concentrations markedly outside reference interval. For the remaining 17 dogs, Bland-Altman ratio analysis of cortisol concentration (tetracosactide/Synacthen®) at 1 h found virtually no constant bias (mean of ratios 1.01;95% CI 0.97-1.05) and 95% limits of agreement were 0.88 (95% CI 0.78-0.90) and 1.17 (95% CI 1.13-1.25). This met our criteria for agreement between cortisol concentrations. Bias of the Bland-Altman difference was 2.8 nmol/L (95% CI -7.2 to 12.8); 95% limits of agreement -35.2 nmol/L (95% CI -57.0 to -26.1) and 40.8 nmol/L (95% CI 31.7-62.6). Passing-Bablok regression analysis did not identify bias. CONCLUSION In healthy dogs, cortisol concentrations were in agreement after compounded tetracosactide compared to commercial tetracosactide, Synacthen®.
Collapse
Affiliation(s)
- W Yang
- Small Animal Medicine, Veterinary Specialists Aotearoa, Auckland, New Zealand
| | - G Hosgood
- School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia
| | - S Foster
- Clinical Pathology, Vetnostics, North Ryde, New South Wales, Australia
| | - K Langner
- Internal Medicine, Western Australian Veterinary Emergency and Specialty, Success, Western Australia, Australia
| | - D Hayward
- School of Veterinary Medicine, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, Western Australia, Australia
| | - M Thompson
- Sydney School of Veterinary Science, University Veterinary Teaching Hospital Sydney, Camperdown, New South Wales, Australia
| |
Collapse
|
5
|
Chapman J, Wegman M, Thompson M, Barrett M. 216 Impact of Proposed Core Faculty Protected Time Requirements: National Survey of Emergency Medicine Faculty on Work Hours and Associated Job Satisfaction. Ann Emerg Med 2022. [DOI: 10.1016/j.annemergmed.2022.08.241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Cifaldi A, Thompson M, Abicht B. Tibiotalocalcaneal Arthrodesis with Structural Allograft for Management of Large Osseous Defects of the Hindfoot and Ankle: A Systematic Review and Meta-Analysis. J Foot Ankle Surg 2022; 61:900-906. [PMID: 35585002 DOI: 10.1053/j.jfas.2022.01.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 05/26/2021] [Accepted: 01/10/2022] [Indexed: 02/03/2023]
Abstract
Large osseous defects of the hindfoot and ankle pose a surgical challenge. Tibiotalocalcaneal (TTC) arthrodesis utilizing a structural allograft may be required to fill the osseous void, preserve limb length and achieve fusion. Several authors have reported small case series on this topic, however outcomes have varied and no systematic review of this data has been published to date. The primary aim of this study is to report rates of osseous union, limb salvage and complications in patients undergoing TTC arthrodesis with a structural allograft. A total of 11 publications were identified that met the inclusion criteria. One hundred seventy-five patients were included with a weighted mean age of 60.5 (range 50-72) years and follow-up period of 29.7 (range 3-62) months. Femoral head allograft was the most commonly utilized structural graft and a retrograde intramedullary nail was the most common fixation construct. Results demonstrated an overall union rate of 67.4%, limb salvage rate of 92.5% and complication rate of 26.6%. Allograft-related complications were rare with an allograft fracture rate of 0.1% and allograft collapse rate of 1.2%. There was no significant difference in union rate when using a retrograde intramedullary nail versus a plate construct (p = .9148). TTC arthrodesis with use of a structural allograft is a viable treatment option for limb salvage when faced with complex hindfoot and ankle pathology involving large osseous defects. Despite high rates of radiographic nonunion, this approach can provide patients with a stable and functional limb while avoiding amputation.
Collapse
Affiliation(s)
- Andrea Cifaldi
- Podiatric Medicine and Surgery Resident, Gundersen Medical Foundation, La Crosse, WI.
| | - Mitchell Thompson
- Podiatric Medicine and Surgery Resident, Gundersen Medical Foundation, La Crosse, WI
| | - Bradley Abicht
- Department Chair and Attending Staff, Podiatry Department within Orthopaedic Center, Gundersen Health System, La Crosse, WI
| |
Collapse
|
7
|
Westman ME, Coggins SJ, van Dorsselaer M, Norris JM, Squires RA, Thompson M, Malik R. Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management. Aust Vet J 2022; 100:345-359. [PMID: 35578381 PMCID: PMC9546031 DOI: 10.1111/avj.13166] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 04/13/2022] [Accepted: 04/16/2022] [Indexed: 01/25/2023]
Abstract
Despite the passage of over 30 years since its discovery, the importance of feline immunodeficiency virus (FIV) on the health and longevity of infected domestic cats is hotly debated amongst feline experts. Notwithstanding the absence of good quality information, Australian and New Zealand (NZ) veterinarians should aim to minimise the exposure of cats to FIV. The most reliable way to achieve this goal is to recommend that all pet cats are kept exclusively indoors, or with secure outdoor access (e.g., cat enclosures, secure gardens), with FIV testing of any in‐contact cats. All animal holding facilities should aim to individually house adult cats to limit the spread of FIV infection in groups of animals that are stressed and do not have established social hierarchies. Point‐of‐care (PoC) FIV antibody tests are available in Australia and NZ that can distinguish FIV‐infected and uninfected FIV‐vaccinated cats (Witness™ and Anigen Rapid™). Although testing of whole blood, serum or plasma remains the gold standard for FIV diagnosis, PoC testing using saliva may offer a welfare‐friendly alternative in the future. PCR testing to detect FIV infection is not recommended as a screening procedure since a negative PCR result does not rule out FIV infection and is only recommended in specific scenarios. Australia and NZ are two of three countries where a dual subtype FIV vaccine (Fel‐O‐Vax® FIV) is available and offers a further avenue for disease prevention. Since FIV vaccination only has a reported field effectiveness of 56% in Australia, and possibly lower in NZ, FIV‐vaccinated cats should undergo annual FIV testing prior to annual FIV re‐vaccination using a suitable PoC kit to check infection has not occurred in the preceding year. With FIV‐infected cats, clinicians should strive to be even more thorough than usual at detecting early signs of disease. The most effective way to enhance the quality of life and life expectancy of FIV‐infected cats is to optimise basic husbandry and to treat any concurrent conditions early in the disease course. Currently, no available drugs are registered for the treatment of FIV infection. Critically, the euthanasia of healthy FIV‐infected cats, and sick FIV‐infected cats without appropriate clinical investigations, should not occur.
Collapse
Affiliation(s)
- M E Westman
- Sydney School of Veterinary Science, The University of Sydney, Sydney, New South Wales, Australia
| | - S J Coggins
- Sydney School of Veterinary Science, The University of Sydney, Sydney, New South Wales, Australia
| | | | - J M Norris
- Sydney School of Veterinary Science, The University of Sydney, Sydney, New South Wales, Australia.,The Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, New South Wales, Australia
| | - R A Squires
- College of Public Health, Medical & Veterinary Sciences, James Cook University, Townsville, Queensland, Australia
| | - M Thompson
- Sydney School of Veterinary Science, The University of Sydney, Sydney, New South Wales, Australia
| | - R Malik
- Centre for Veterinary Education, The University of Sydney, Sydney, New South Wales, Australia.,School of Veterinary and Animal Science, Charles Sturt University, Wagga Wagga, New South Wales, Australia
| |
Collapse
|
8
|
Stewart J, Pienta M, Cascino T, Thompson M, Pagani F, Likosky D. Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
9
|
Stoner B, Cao X, Kolodziej A, Villegas-Galaviz J, Campbell K, Thompson M, Birks E, Vaidya G. Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
10
|
Wolfenden G, James FE, Hung LHT, Bruce M, Thompson M. Comparative accuracy of two veterinary‐calibrated point‐of‐care glucometres for measurement of blood glucose concentration in dogs. J Small Anim Pract 2022; 63:512-519. [DOI: 10.1111/jsap.13491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Revised: 01/23/2022] [Accepted: 02/05/2022] [Indexed: 11/27/2022]
Affiliation(s)
| | | | | | - M. Bruce
- School of Veterinary Medicine and Centre for Biosecurity and One Health Murdoch University Murdoch 6150 Australia
| | - M. Thompson
- Sydney School of Veterinary Science The University of Sydney Camperdown 2050 Australia
| |
Collapse
|
11
|
Poon-King A, Brunner C, Lloyd R, Jones L, Eccles G, Sprague H, Wright S, Selby A, Jennings R, Foyle S, Apostolopousy F, Johns J, Thompson M, Berney-Smith P, Howells T, Nicholas O, Banner R, Christopher E, Gwynne S. Creating a Standardised Pathway for Patients at Risk of Radiotherapy (RT) Induced Hyposplenism in a Single Cancer Centre. Clin Oncol (R Coll Radiol) 2022. [DOI: 10.1016/j.clon.2022.01.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
12
|
Meyer J, Thompson M, Ross S. 90: Improving research awareness and engagement in a pediatric cystic fibrosis center. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01515-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
13
|
Thompson M, Reed J, Moran S, Sanders D, Ren C. 74: Factors contributing to clinician responses to FEV1 indicated exacerbation signal (FIES) events in a pediatric CF clinic. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01499-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
14
|
Travis S, Thompson M. 502: Combating fosfomycin resistance in CF-related bacterial lung infections. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01926-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Curtin G, McCarthy S, Cooney C, Spencer K, Thompson M. 948 Feasibility Study of a Drive-Through Influenza Vaccination Clinic for Patients-At-Risk & Their Contacts. Br J Surg 2021. [PMCID: PMC8524481 DOI: 10.1093/bjs/znab259.758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Background There are 3-5 million cases of severe influenza-like illness globally each year, and up to 650,000 related deaths. This high prevalence rate proves to be a heavy burden on the healthcare system with >3,000 hospitalisations and >150 ICU admissions annually. Immunisation is gold-standard for the prevention of influenza outbreaks. The HSE Influenza Immunisation Strategy allocates vaccines to be administered in primary care to patients at-risk and their contacts. However, due to the COVID-19 pandemic, this has become a logistical challenge. We aimed to design and test a drive-through influenza vaccine clinic at a large GP practice in Cork. Method We designed and implemented an online booking system for at-risk patients and their contacts. 1-minute drive-through time slots were available to book for up to 6 people per vehicle. The primary measurement was the number of patients vaccinated with a secondary measurement of time spent vaccinating these patients. Results The pilot clinic occurred on 10/10/2020 with over 600 patients-at-risk & their contacts receiving the influenza vaccination over a time period of 10 hours. The capacity of this clinic was limited by the supply of vaccines. We estimate that 1,800 people could be vaccinated over the same time period with adequate vaccine supply. Conclusions A drive-through influenza vaccination clinic can be efficiently run using an online booking system and serves as a safe, efficient, and convenient way for patients-at-risk & their contacts to receive vaccinations. This system can be rolled out efficiently each winter for influenza vaccination and could be expanded to deliver mass vaccination for SARS-CoV-2.
Collapse
Affiliation(s)
- G Curtin
- University College Cork, Cork, Ireland
| | - S McCarthy
- Ballycotton Medical Centre, Cork, Ireland
| | - C Cooney
- Imokilly Medical Centre, Cork, Ireland
| | - K Spencer
- Imokilly Medical Centre, Cork, Ireland
| | | |
Collapse
|
16
|
Cohen R, Borzutzky C, Wilkinson TA, Thompson M, Collins J. POSTER ABSTRACTS. Contraception 2021. [DOI: 10.1016/j.contraception.2021.07.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Khan M, Aristotelous C, Maharaj K, Thompson M. A Rare Case of Pott's Puffy Tumor in an Elderly Man with a Background of Schizophrenia. J Oral Maxillofac Surg 2021. [DOI: 10.1016/j.joms.2021.08.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
18
|
Ledoux T, Alexander T, Thompson M, Olmedo C, Arbona C, Olvera N. Experiential Internship to Encourage Hispanic Students to Enter the Nutrition and Dietetics Professions. J Acad Nutr Diet 2021. [DOI: 10.1016/j.jand.2021.08.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
19
|
Khaddour L, Zhang C, Ali F, Gadgeel S, Tadesse E, Thompson M, Reding D, Treisman J, Berry A, Izano M, Sweetnam C, Stafford A, Wolf F, Brown T, Rybkin I. P10.04 Immunotherapy-Treated Non-Small Cell Lung Cancer Patients With Sensitizing Gene Alterations: A Real World Survival Analysis. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.309] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Adler C, Ahammed Z, Allgower C, Amonett J, Anderson BD, Anderson M, Averichev GS, Balewski J, Barannikova O, Barnby LS, Baudot J, Bekele S, Belaga VV, Bellwied R, Berger J, Bichsel H, Billmeier A, Bland LC, Blyth CO, Bonner BE, Boucham A, Brandin A, Bravar A, Cadman RV, Caines H, Calderón de la Barca Sánchez M, Cardenas A, Carroll J, Castillo J, Castro M, Cebra D, Chaloupka P, Chattopadhyay S, Chen Y, Chernenko SP, Cherney M, Chikanian A, Choi B, Christie W, Coffin JP, Cormier TM, Cramer JG, Crawford HJ, Csanád M, Deng WS, Derevschikov AA, Didenko L, Dietel T, Draper JE, Dunin VB, Dunlop JC, Eckardt V, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Fachini P, Faine V, Filimonov K, Finch E, Fisyak Y, Flierl D, Foley KJ, Fu J, Gagliardi CA, Gagunashvili N, Gans J, Gaudichet L, Germain M, Geurts F, Ghazikhanian V, Grachov O, Grigoriev V, Guedon M, Gushin E, Hallman TJ, Hardtke D, Harris JW, Henry TW, Heppelmann S, Herston T, Hippolyte B, Hirsch A, Hjort E, Hoffmann GW, Horsley M, Huang HZ, Humanic TJ, Igo G, Ishihara A, Ivanshin YI, Jacobs P, Jacobs WW, Janik M, Johnson I, Jones PG, Judd EG, Kaneta M, Kaplan M, Keane D, Kiryluk J, Kisiel A, Klay J, Klein SR, Klyachko A, Konstantinov AS, Kopytine M, Kotchenda L, Kovalenko AD, Kramer M, Kravtsov P, Krueger K, Kuhn C, Kulikov AI, Kunde GJ, Kunz CL, Kutuev RK, Kuznetsov AA, Lakehal-Ayat L, Lamont MAC, Landgraf JM, Lange S, Lansdell CP, Lasiuk B, Laue F, Lebedev A, Lednický R, Leontiev VM, LeVine MJ, Li Q, Lindenbaum SJ, Lisa MA, Liu F, Liu L, Liu Z, Liu QJ, Ljubicic T, Llope WJ, LoCurto G, Long H, Longacre RS, Lopez-Noriega M, Love WA, Ludlam T, Lynn D, Ma J, Ma R, Majka R, Margetis S, Markert C, Martin L, Marx J, Matis HS, Matulenko YA, McShane TS, Meissner F, Melnick Y, Meschanin A, Messer M, Miller ML, Milosevich Z, Minaev NG, Mitchell J, Moiseenko VA, Moore CF, Morozov V, de Moura MM, Munhoz MG, Nelson JM, Nevski P, Niida T, Nikitin VA, Nogach LV, Norman B, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Paic G, Pandey SU, Panebratsev Y, Panitkin SY, Pavlinov AI, Pawlak T, Perevoztchikov V, Peryt W, Petrov VA, Planinic M, Pluta J, Porile N, Porter J, Poskanzer AM, Potrebenikova E, Prindle D, Pruneau C, Putschke J, Rai G, Rakness G, Ravel O, Ray RL, Razin SV, Reichhold D, Reid JG, Retiere F, Ridiger A, Ritter HG, Roberts JB, Rogachevski OV, Romero JL, Rose A, Roy C, Rykov V, Sakrejda I, Salur S, Sandweiss J, Saulys AC, Savin I, Schambach J, Scharenberg RP, Schmitz N, Schroeder LS, Schüttauf A, Schweda K, Seger J, Seliverstov D, Seyboth P, Shahaliev E, Shestermanov KE, Shimanskii SS, Shvetcov VS, Skoro G, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stephenson EJ, Stock R, Stolpovsky A, Strikhanov M, Stringfellow B, Struck C, Suaide AAP, Sugarbaker E, Suire C, Šumbera M, Surrow B, Symons TJM, Szanto de Toledo A, Szarwas P, Tai A, Takahashi J, Tang AH, Thomas JH, Thompson M, Tikhomirov V, Todoroki T, Tokarev M, Tonjes MB, Trainor TA, Trentalange S, Tribble RE, Trofimov V, Tsai O, Ullrich T, Underwood DG, Van Buren G, VanderMolen AM, Vasilevski IM, Vasiliev AN, Vigdor SE, Voloshin SA, Wang F, Ward H, Watson JW, Wells R, Westfall GD, Whitten C, Wieman H, Willson R, Wissink SW, Witt R, Wood J, Xu N, Xu Z, Yakutin AE, Yamamoto E, Yang J, Yepes P, Yurevich VI, Zanevski YV, Zborovský I, Zhang H, Zhang WM, Zoulkarneev R, Zubarev AN. Erratum: Azimuthal Anisotropy of K_{S}^{0} and Λ+Λ[over ¯] Production at Midrapidity from Au+Au Collisions at sqrt[s]_{NN}=130 GeV [Phys. Rev. Lett. 89, 132301 (2002)]. Phys Rev Lett 2021; 127:089901. [PMID: 34477449 DOI: 10.1103/physrevlett.127.089901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/27/2021] [Indexed: 06/13/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.89.132301.
Collapse
|
21
|
Silverthorne C, Daniels J, Thompson M, Robson J, Ndosi M, Swales C, Wilkins K, Dures E. POS1472-HPR CLINICIANS’ PERSPECTIVES ON PSYCHOLOGICAL DISTRESS AND MEETING PATIENTS’ SUPPORT NEEDS IN RHEUMATOLOGY CARE SETTINGS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.2429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:People with inflammatory rheumatic diseases (IRDs) face challenges that include fluctuations in pain, fatigue and flares of disease activity, complex medical regimens, and decisions about when to seek clinical help with symptoms [1,2]. Evidence suggests levels of anxiety and depression are higher in people with IRDs compared to the general population [3]. Rheumatology teams report that psychologically distressed patients can have additional support needs and require more time. Patients’ concerns include health-related anxiety and difficulty accepting the diagnosis. This group can have poor outcomes and poor adherence to treatments. However, little is currently known about optimal ways to meet these patients’ support needs.Objectives:To understand rheumatology clinicians’ perspectives on psychological distress in care settings with the long-term aim to develop a proposed model/pathway of support.Methods:Telephone interviews were conducted with members of UK rheumatology teams who have clinical experience with patients experiencing distress. The semi-structured interviews explored both ‘what happens now’ (current clinical practice) and ‘what should happen’ (acceptable models of future psychological support provision). The semi-structured format provided flexibility to probe more deeply and develop new lines of enquiry based on participants’ responses.Results:Fourteen interviews were conducted with rheumatology clinicians including 2 consultants, 4 nurses, 1 physiotherapist, 4 occupational therapists, 2 clinical psychologists and 1 podiatrist. Inductive thematic analysis was used to analyse the data. Two main themes represent the data (Table 1).Table 1.Main ThemeSub-themes1. ‘No one shoe fits all’ – the many manifestations of distress in patients.‘I pick up on distress as increased emotion…tearfulness and sadness I suppose, but also frustration, anger...A lot of helplessness comments’1. ‘Distress can be quite emotive and quite obvious, but then it can also hide away’2. ‘They’re [patients] trying to manage their own conditions, but they’re also trying to manage life’2. ‘If Rheumatology could be interwoven with psychological principles’ – the need to attend to the psychological impact of IRDs, alongside the physical impact.‘The physical and mental health side of things are so closely linked because one affects the other…after a while they [patients] don’t really know what’s affecting what’1. ‘Prioritising physical health…sometimes the stress gets not thought about’2. ‘Make best use of everyone in the team to work with patients who are struggling’3. ‘For the psychological side of things we don’t measure anything about that at all’Conclusion:Distress can be obvious or hidden and cause issues for both patient and clinician. It can lead to poor engagement with care provision. Clinicians differ in their perceptions of distress and in their thresholds for dealing with distress and have described the inconsistency of support offered for distressed patients. They described the powerful link between physical and mental distress, the vicious cycle that can develop, and the benefits of incorporating a psychological approach to treatment. This study suggests psychological support should be embedded within the team as it is felt there is a need for speciality understanding and for patients’ emotional wellbeing to consistently be given equal priority to their physical wellbeing.References:[1]Gettings L. Psychological well-being in rheumatoid arthritis: a review of the literature. Musculoskeletal care 2010;8(2):99-106. doi: 10.1002/msc.171 [published Online First: 2010/03/17][2]Homer D. Addressing psychological and social issues of rheumatoid arthritis within the consultation: a case report. Musculoskeletal care 2005;3(1):54-9. doi: 10.1002/msc.26 [published Online First: 2006/10/17][3]Isik A, Koca SS, Ozturk A, et al. Anxiety and depression in patients with rheumatoid arthritis. Clinical rheumatology 2007;26(6):872-8. doi: 10.1007/s10067-006-0407-y [published Online First: 2006/08/31]Disclosure of Interests:None declared
Collapse
|
22
|
Staruch RMT, Spear AM, Edwards J, Rickard R, Thompson M. O3: EVALUATION OF A 3D PRINTED BIO-ARTIFICIAL MUSCLE-ORGANOID FOR TRAUMA RESEARCH. Br J Surg 2021. [DOI: 10.1093/bjs/znab117.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Introduction
Organoid models serve as a robust platform for investigating injury and disease in vitro. Currently, representative models of injury are lacking to investigate the effects of traumatic damage to organs and tissues. Here we describe a three-dimensional in vitro model of high strain rate loading seen in traumatic blast injury.
Method
3D printing resins were tested for Young's Modulus & Poisson Ratio using a universal testing Organoids were then loaded into a 3D Printed bioreactor for high strain rate loading using a split Hopkinson pressure bar device. machine and digital image. Euler beam theory was used to evaluate post deflection. C2C12 myoblasts were seeded in fibrin hydrogels around 3D printed posts using a custom designed jig. High strain rate loading was applied to constructs, then qPCR & Fluorescent Live/Dead staining was utilised to demonstrate cell alignment and myotube formation.
Result
Young's modulus of Flexible resin was 11.51Mpa. Differentiated C2C12 myoblasts were capable of alignment between posts and expression of key markers of differentiation shown by qPCR & imaging. MYH5, MYH2 & MYH1 all had a > 1.5 old increase in expression compared to undifferentiated controls. Organoids were capable of survival in bioreactor casings for over 24 hours and were intact after application of high strain rate loading.
Conclusion
This work demonstrates the first use of a 3D printed organoid in vitro model to investigate high strain rate loading for trauma research. This organoid is capable of high throughput analysis to facilitate genomic and protein level expression analysis.
Take-home message
This work demonstrates the first use of a 3D printed organoid in vitro model to investigate high strain rate loading for trauma research.
Collapse
Affiliation(s)
- RMT Staruch
- University of Oxford
- Academic Department of Military Surgery & Trauma
| | - AM Spear
- Defence Science & Technology Laboratories
| | | | - R Rickard
- Academic Department of Military Surgery & Trauma
| | | |
Collapse
|
23
|
Hayes AG, Corlies P, Tate C, Barrington M, Bell JF, Maki JN, Caplinger M, Ravine M, Kinch KM, Herkenhoff K, Horgan B, Johnson J, Lemmon M, Paar G, Rice MS, Jensen E, Kubacki TM, Cloutis E, Deen R, Ehlmann BL, Lakdawalla E, Sullivan R, Winhold A, Parkinson A, Bailey Z, van Beek J, Caballo-Perucha P, Cisneros E, Dixon D, Donaldson C, Jensen OB, Kuik J, Lapo K, Magee A, Merusi M, Mollerup J, Scudder N, Seeger C, Stanish E, Starr M, Thompson M, Turenne N, Winchell K. Pre-Flight Calibration of the Mars 2020 Rover Mastcam Zoom (Mastcam-Z) Multispectral, Stereoscopic Imager. Space Sci Rev 2021; 217:29. [PMID: 33678912 PMCID: PMC7892537 DOI: 10.1007/s11214-021-00795-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Accepted: 01/12/2021] [Indexed: 05/28/2023]
Abstract
UNLABELLED The NASA Perseverance rover Mast Camera Zoom (Mastcam-Z) system is a pair of zoomable, focusable, multi-spectral, and color charge-coupled device (CCD) cameras mounted on top of a 1.7 m Remote Sensing Mast, along with associated electronics and two calibration targets. The cameras contain identical optical assemblies that can range in focal length from 26 mm ( 25.5 ∘ × 19.1 ∘ FOV ) to 110 mm ( 6.2 ∘ × 4.2 ∘ FOV ) and will acquire data at pixel scales of 148-540 μm at a range of 2 m and 7.4-27 cm at 1 km. The cameras are mounted on the rover's mast with a stereo baseline of 24.3 ± 0.1 cm and a toe-in angle of 1.17 ± 0.03 ∘ (per camera). Each camera uses a Kodak KAI-2020 CCD with 1600 × 1200 active pixels and an 8 position filter wheel that contains an IR-cutoff filter for color imaging through the detectors' Bayer-pattern filters, a neutral density (ND) solar filter for imaging the sun, and 6 narrow-band geology filters (16 total filters). An associated Digital Electronics Assembly provides command data interfaces to the rover, 11-to-8 bit companding, and JPEG compression capabilities. Herein, we describe pre-flight calibration of the Mastcam-Z instrument and characterize its radiometric and geometric behavior. Between April 26 t h and May 9 t h , 2019, ∼45,000 images were acquired during stand-alone calibration at Malin Space Science Systems (MSSS) in San Diego, CA. Additional data were acquired during Assembly Test and Launch Operations (ATLO) at the Jet Propulsion Laboratory and Kennedy Space Center. Results of the radiometric calibration validate a 5% absolute radiometric accuracy when using camera state parameters investigated during testing. When observing using camera state parameters not interrogated during calibration (e.g., non-canonical zoom positions), we conservatively estimate the absolute uncertainty to be < 10 % . Image quality, measured via the amplitude of the Modulation Transfer Function (MTF) at Nyquist sampling (0.35 line pairs per pixel), shows MTF Nyquist = 0.26 - 0.50 across all zoom, focus, and filter positions, exceeding the > 0.2 design requirement. We discuss lessons learned from calibration and suggest tactical strategies that will optimize the quality of science data acquired during operation at Mars. While most results matched expectations, some surprises were discovered, such as a strong wavelength and temperature dependence on the radiometric coefficients and a scene-dependent dynamic component to the zero-exposure bias frames. Calibration results and derived accuracies were validated using a Geoboard target consisting of well-characterized geologic samples. SUPPLEMENTARY INFORMATION The online version contains supplementary material available at 10.1007/s11214-021-00795-x.
Collapse
Affiliation(s)
- Alexander G. Hayes
- Department of Astronomy, Cornell University, Ithaca, NY 14850 USA
- Cornell Center for Astrophysics and Planetary Science, Cornell University, Ithaca, NY 14850 USA
| | - P. Corlies
- Department of Astronomy, Cornell University, Ithaca, NY 14850 USA
- Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - C. Tate
- Department of Astronomy, Cornell University, Ithaca, NY 14850 USA
| | - M. Barrington
- Department of Astronomy, Cornell University, Ithaca, NY 14850 USA
| | - J. F. Bell
- School of Earth and Space Exploration, Arizona State University, Phoenix, AZ 85287 USA
| | - J. N. Maki
- Jet Propulsion Laboratory, Pasadena, CA 91109 USA
| | - M. Caplinger
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - M. Ravine
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - K. M. Kinch
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - K. Herkenhoff
- USGS Astrogeology Science Center, 2255 N. Gemini Drive, Flagstaff, AZ 86001 USA
| | - B. Horgan
- Earth, Atmospheric, and Planetary Sciences Department, Purdue University, West Lafayette, IN 47907 USA
| | - J. Johnson
- Johns Hopkins Applied Physics Laboratory, Laurel, MD 20723 USA
| | - M. Lemmon
- Space Science Institute, 4765 Walnut St., Suite B, Boulder, CO 80301 USA
| | - G. Paar
- Joanneum Research Forschungsgesellschaft mbH, Steyrergasse 17, 8010 Graz, Austria
| | - M. S. Rice
- Geology Department, Western Washington University, Bellingham, WA 98225 USA
| | - E. Jensen
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - T. M. Kubacki
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - E. Cloutis
- Geography Department, University of Winnepeg, 515 Portage Ave, Winnipeg, MB R3B 2E9 Canada
| | - R. Deen
- Jet Propulsion Laboratory, Pasadena, CA 91109 USA
| | - B. L. Ehlmann
- Jet Propulsion Laboratory, Pasadena, CA 91109 USA
- Division of Geological and Planetary Sciences, California Institute of Technology, Pasadena, CA 91101 USA
| | - E. Lakdawalla
- The Planetary Society, 60 S Los Robles, Pasadena, CA 91101 USA
| | - R. Sullivan
- Cornell Center for Astrophysics and Planetary Science, Cornell University, Ithaca, NY 14850 USA
| | - A. Winhold
- School of Earth and Space Exploration, Arizona State University, Phoenix, AZ 85287 USA
| | - A. Parkinson
- Centre for Terrestrial and Planetary Exploration, University of Winnipeg, 515 Portage Ave, Winnipeg, MB R3B 2E9 Canada
| | - Z. Bailey
- Jet Propulsion Laboratory, Pasadena, CA 91109 USA
| | - J. van Beek
- Jet Propulsion Laboratory, Pasadena, CA 91109 USA
| | - P. Caballo-Perucha
- Joanneum Research Forschungsgesellschaft mbH, Steyrergasse 17, 8010 Graz, Austria
| | - E. Cisneros
- School of Earth and Space Exploration, Arizona State University, Phoenix, AZ 85287 USA
| | - D. Dixon
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - C. Donaldson
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - O. B. Jensen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - J. Kuik
- Centre for Terrestrial and Planetary Exploration, University of Winnipeg, 515 Portage Ave, Winnipeg, MB R3B 2E9 Canada
| | - K. Lapo
- Geology Department, Western Washington University, Bellingham, WA 98225 USA
| | - A. Magee
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - M. Merusi
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - J. Mollerup
- Geology Department, Western Washington University, Bellingham, WA 98225 USA
| | - N. Scudder
- Earth, Atmospheric, and Planetary Sciences Department, Purdue University, West Lafayette, IN 47907 USA
| | - C. Seeger
- Geology Department, Western Washington University, Bellingham, WA 98225 USA
| | - E. Stanish
- Centre for Terrestrial and Planetary Exploration, University of Winnipeg, 515 Portage Ave, Winnipeg, MB R3B 2E9 Canada
| | - M. Starr
- Malin Space Science Systems, San Diego, CA 92121 USA
| | - M. Thompson
- Jet Propulsion Laboratory, Pasadena, CA 91109 USA
| | - N. Turenne
- Centre for Terrestrial and Planetary Exploration, University of Winnipeg, 515 Portage Ave, Winnipeg, MB R3B 2E9 Canada
| | - K. Winchell
- Malin Space Science Systems, San Diego, CA 92121 USA
| |
Collapse
|
24
|
Thoene M, Furtado J, Thompson M, Van Ormer M, Hanson C, Anderson-Berry A. Intrauterine transfer of Fat-soluble nutrients as analyzed at time of delivery. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
Mullally A, Horgan T, Thompson M, Conlon C, Dempsey B, Higgins M. Working in the shadows, under the spotlight – Reflections on lessons learnt in the Republic of Ireland after the first 18 months of more liberal Abortion Care. Contraception 2020; 102:305-307. [DOI: 10.1016/j.contraception.2020.07.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Revised: 06/30/2020] [Accepted: 07/01/2020] [Indexed: 12/01/2022]
|
26
|
Park MR, Chen Y, Thompson M, Benites VT, Fong B, Petzold CJ, Baidoo EEK, Gladden JM, Adams PD, Keasling JD, Simmons BA, Singer SW. Response of Pseudomonas putida to Complex, Aromatic-Rich Fractions from Biomass. ChemSusChem 2020; 13:4455-4467. [PMID: 32160408 DOI: 10.1002/cssc.202000268] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 03/11/2020] [Indexed: 06/10/2023]
Abstract
There is strong interest in the valorization of lignin to produce valuable products; however, its structural complexity has been a conversion bottleneck. Chemical pretreatment liberates lignin-derived soluble fractions that may be upgraded by bioconversion. Cholinium ionic liquid pretreatment of sorghum produced soluble, aromatic-rich fractions that were converted by Pseudomonas putida (P. putida), a promising host for aromatic bioconversion. Growth studies and mutational analysis demonstrated that P. putida growth on these fractions was dependent on aromatic monomers but unknown factors also contributed. Proteomic and metabolomic analyses indicated that these unknown factors were amino acids and residual ionic liquid; the oligomeric aromatic fraction derived from lignin was not converted. A cholinium catabolic pathway was identified, and the deletion of the pathway stopped the ability of P. putida to grow on cholinium ionic liquid. This work demonstrates that aromatic-rich fractions obtained through pretreatment contain multiple substrates; conversion strategies should account for this complexity.
Collapse
Affiliation(s)
- Mee-Rye Park
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Yan Chen
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Mitchell Thompson
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Veronica T Benites
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Bonnie Fong
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Christopher J Petzold
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Edward E K Baidoo
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - John M Gladden
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biomass Science and Conversion Technology, Sandia National Laboratories, 7011 East Avenue, Livermore, CA, 94551, USA
| | - Paul D Adams
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Department of Bioengineering, University of California, Berkeley, CA, 94720, USA
| | - Jay D Keasling
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Department of Bioengineering, University of California, Berkeley, CA, 94720, USA
- Department of Chemical & Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA
- Center for Biosustainability, Danish Technical University, Lyngby, Denmark
- Center for Synthetic Biochemistry, Institute for Synthetic Biology, Shenzhen Institutes for Advanced Technology, Shenzhen, China
| | - Blake A Simmons
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| | - Steven W Singer
- Joint BioEnergy Institute, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA
| |
Collapse
|
27
|
Allison LN, Jaffey JA, Bradley-Siemens N, Tao Z, Thompson M, Backus RC. Immune function and serum vitamin D in shelter dogs: A case-control study. Vet J 2020; 261:105477. [PMID: 32741494 DOI: 10.1016/j.tvjl.2020.105477] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Revised: 05/28/2020] [Accepted: 05/28/2020] [Indexed: 11/28/2022]
Abstract
This study sought to establish a baseline understanding of immune function and its association with serum vitamin D in shelter dogs. Ten apparently healthy shelter dogs housed in the Arizona Humane Society for ≥7 days and 10 apparently healthy, age, breed, and sex-matched control dogs were included. Serum 25-hydroxyvitamin D (25[OH]D), the major circulating vitamin D metabolite, was measured using high performance liquid chromatography. Whole blood samples were stimulated with lipopolysaccharide (LPS), lipoteichoic acid, or phosphate buffer solution, and tumor necrosis factor (TNF)-ɑ, interleukin (IL)-6, and IL-10 were measured using a canine-specific multiplex bead-based assay. Phagocytosis of opsonized-Escherichia coli and E. coli-induced oxidative burst were evaluated with flow cytometry. Shelter dogs had decreased percentages of granulocytes and monocytes (GM) that had phagocytized opsonized-E coli (P = 0.019) and performed E. coli-induced oxidative burst (P = 0.011). There were no significant differences in TNF-α, IL-6, IL-10, or 25(OH)D concentrations between shelter and control dogs. Serum 25(OH)D concentrations had a weak positive association with the intensity of GM E. coli-induced oxidative burst (r2 = 0.23, P = 0.03). There was a moderate inverse association between serum 25(OH)D concentration and LPS-stimulated TNF-ɑ production in shelter dogs (r2 = 0.40, P = 0.04). These results demonstrate immune dysregulation in vitro in shelter dogs housed for ≥7 days when compared to age, breed, and sex-matched control dogs. While serum 25(OH)D concentrations did not differ between shelter and control dogs, significant associations between 25(OH)D concentration and immune function parameters in vitro were identified.
Collapse
Affiliation(s)
- L N Allison
- Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, 19555 N 59th Ave, Glendale, AZ 85308, USA
| | - J A Jaffey
- Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, 19555 N 59th Ave, Glendale, AZ 85308, USA.
| | - N Bradley-Siemens
- Department of Pathology and Population Medicine, College of Veterinary Medicine, Midwestern University, 19555 N 59th Ave, Glendale, AZ 85308, USA
| | - Z Tao
- Department of Specialty Medicine, College of Veterinary Medicine, Midwestern University, 19555 N 59th Ave, Glendale, AZ 85308, USA
| | - M Thompson
- Arizona Humane Society, 9226 N 13th Ave, Phoenix, AZ 85021, USA
| | - R C Backus
- Department of Veterinary Medicine and Surgery, Veterinary Health Center, University of Missouri, 900 E Campus Dr, Columbia, MO 65211, USA
| |
Collapse
|
28
|
CHADHA V, Garg U, Thompson M, Daniel J, Rowzer K, Heese B, Gannon J. SUN-473 STANDARDIZED CARE MODEL TO IMPROVE OUTCOME FOR NEWBORNS WITH INBORN ERROR OF METABOLISM REQUIRING URGENT DIALYSIS THERAPY. Kidney Int Rep 2020. [DOI: 10.1016/j.ekir.2020.02.1016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
29
|
Al Dabhani D, Thompson M, Bolgar G, Pua B, Charalel R. 3:54 PM Abstract No. 78 New clinic workflow improves compliance for routine percutaneous nephrostomy tube exchanges. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
30
|
Bernard E, Sakamoto R, Hodille E, Kreter A, Autissier E, Barthe MF, Desgardin P, Schwarz-Selinger T, Burwitz V, Feuillastre S, Garcia-Argote S, Pieters G, Rousseau B, Ialovega M, Bisson R, Ghiorghiu F, Corr C, Thompson M, Doerner R, Markelj S, Yamada H, Yoshida N, Grisolia C. Corrigendum to “Tritium retention in w plasma-facing materials: Impact of the material structure and helium irradiation” [Nucl. Mater. Energy 2019; 19: 403–410]. Nuclear Materials and Energy 2020. [DOI: 10.1016/j.nme.2020.100729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
31
|
Snee M, Cheeseman S, Thompson M, Bowman R, Lacoin L, Sopwith W, Chaib C, Daumont M, Penrod J, O’Donnell J, Hall G. Impact of second-line (2L) immune checkpoint inhibitors (ICIs) on the treatment (Tx) of advanced non-small cell lung cancer (NSCLC) in a UK centre: A REAL-oncology analysis from the I-O Optimise initiative. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
32
|
Snee M, Cheeseman S, Thompson M, Bowman R, Lacoin L, Sopwith W, Chaib C, Juarez-Garcia A, Daumont M, Penrod J, O'Donnell J, Hall G. P2.12-01 Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
33
|
Mahon J, Thompson M, Sandquist M, Raj A, Schadt C, Callen J, Owen C, McGowan K. LB1108 Association of aplastic anemia with isotretinoin: Is it more common than we think? J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.06.073] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
34
|
Santos-Caetano JP, Gfeller CF, Mahalingam H, Thompson M, Moore DJ, Vila R, Doi R, Cargill MR. Cosmetic benefits of a novel biomimetic lamellar formulation containing niacinamide in healthy females with oily, blemish-prone skin in a randomized proof-of-concept study. Int J Cosmet Sci 2019; 42:29-35. [PMID: 31461548 DOI: 10.1111/ics.12576] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2019] [Revised: 07/31/2019] [Accepted: 08/22/2019] [Indexed: 01/09/2023]
Abstract
OBJECTIVE A randomized study was designed to evaluate the potential cosmetic benefit of a biomimetic, niacinamide-containing moisturizing cream in oily, blemish-prone skin. METHODS Healthy adult women with oily, blemish-prone skin were randomized to one of three treatment groups: test, control, or positive control. In the test group, subjects used the test product (containing 4% niacinamide), plus the standard cleanser (Simple® Kind to Skin Moisturizing Facial Wash). In the control group, subjects received no moisturizer but used the standard cleanser. In the positive control group, subjects used Vivatinell Acnecinamide® Gel Cream (containing 4% niacinamide) as a moisturizer and Neutrogena Visibly Clear® Spot Clearing Facial Wash (containing 2% salicylic acid) as a cleanser. The positive control regimen was included to provide a comparison for estimates of effect size. The primary objective was to evaluate skin moisturization as a change from baseline in corneometer values at 8 h for the test regimen vs. the control regimen. Analysis of covariance was applied for the primary efficacy analysis. RESULTS A total of 132 subjects were randomized with 44 included in each treatment group. A significant difference was observed in the primary endpoint for the test regimen compared with the control regimen (least-squares mean difference [95% CI]: 3.12 [0.68, 5.56], P = 0.0128). A trend was observed in favour of the positive control regimen compared with the control regimen. Secondary measurements of moisturization supported the primary efficacy outcome. Assessment of blemishes showed a significant difference between the test regimen vs. the control regimen for change from baseline in mean total blemish count at Week 8 (least-squares mean difference [95% CI]: -1.80 [-3.41, -0.19], P = 0.0290). No statistical comparisons between the positive control group and the test group were performed. CONCLUSION This study provides proof-of-concept evidence that a novel lamellar lipid moisturizer containing niacinamide, in combination with a standard cleanser, can help moisturize the skin and provide an overall improvement in the complexion appearance of people with blemish-prone skin. STUDY REGISTRATION NCT03093181.
Collapse
Affiliation(s)
- J-P Santos-Caetano
- GlaxoSmithKline Brazil, São Paulo - Medical Affairs and Clinical Operations, São Paulo, Brazil
| | - C F Gfeller
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, UK
| | - H Mahalingam
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, 184 Liberty Corner Road, Warren, NJ, 07059, USA
| | - M Thompson
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, UK
| | - D J Moore
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, UK
| | - R Vila
- GlaxoSmithKline Brazil, São Paulo - Medical Affairs and Clinical Operations, São Paulo, Brazil
| | - R Doi
- Azidus Brasil - 507, Rua General Osório, Valinhos, Brazil
| | - M R Cargill
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, UK
| |
Collapse
|
35
|
|
36
|
Touchstone H, Bryd R, Loisate S, Thompson M, Kim S, Puranam K, Senthilnathan AN, Pu X, Beard R, Rubin J, Alwood J, Oxford JT, Uzer G. Recovery of stem cell proliferation by low intensity vibration under simulated microgravity requires LINC complex. NPJ Microgravity 2019; 5:11. [PMID: 31123701 PMCID: PMC6520402 DOI: 10.1038/s41526-019-0072-5] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Accepted: 03/20/2019] [Indexed: 12/20/2022] Open
Abstract
Mesenchymal stem cells (MSC) rely on their ability to integrate physical and spatial signals at load bearing sites to replace and renew musculoskeletal tissues. Designed to mimic unloading experienced during spaceflight, preclinical unloading and simulated microgravity models show that alteration of gravitational loading limits proliferative activity of stem cells. Emerging evidence indicates that this loss of proliferation may be linked to loss of cellular cytoskeleton and contractility. Low intensity vibration (LIV) is an exercise mimetic that promotes proliferation and differentiation of MSCs by enhancing cell structure. Here, we asked whether application of LIV could restore the reduced proliferative capacity seen in MSCs that are subjected to simulated microgravity. We found that simulated microgravity (sMG) decreased cell proliferation and simultaneously compromised cell structure. These changes included increased nuclear height, disorganized apical F-actin structure, reduced expression, and protein levels of nuclear lamina elements LaminA/C LaminB1 as well as linker of nucleoskeleton and cytoskeleton (LINC) complex elements Sun-2 and Nesprin-2. Application of LIV restored cell proliferation and nuclear proteins LaminA/C and Sun-2. An intact LINC function was required for LIV effect; disabling LINC functionality via co-depletion of Sun-1, and Sun-2 prevented rescue of cell proliferation by LIV. Our findings show that sMG alters nuclear structure and leads to decreased cell proliferation, but does not diminish LINC complex mediated mechanosensitivity, suggesting LIV as a potential candidate to combat sMG-induced proliferation loss.
Collapse
Affiliation(s)
- H. Touchstone
- Department of Mechanical and Biomedical Engineering, Boise State University, Boise, ID 83725 USA
| | - R. Bryd
- Department of Mechanical and Biomedical Engineering, Boise State University, Boise, ID 83725 USA
| | - S. Loisate
- Department of Mechanical and Biomedical Engineering, Boise State University, Boise, ID 83725 USA
| | - M. Thompson
- Department of Mechanical and Biomedical Engineering, Boise State University, Boise, ID 83725 USA
| | - S. Kim
- Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 USA
| | - K. Puranam
- Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 USA
| | - A. N. Senthilnathan
- Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 USA
| | - X. Pu
- Biomolecular Research Center, Boise State University, Boise, ID 83725 USA
| | - R. Beard
- Biomolecular Research Center, Boise State University, Boise, ID 83725 USA
| | - J. Rubin
- Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 USA
| | - J. Alwood
- Space Biosciences Division, NASA-Ames Research Center, Mountain View, CA 94035 USA
| | - J. T. Oxford
- Biomolecular Research Center, Boise State University, Boise, ID 83725 USA
| | - G. Uzer
- Department of Mechanical and Biomedical Engineering, Boise State University, Boise, ID 83725 USA
| |
Collapse
|
37
|
Bernard E, Sakamoto R, Hodille E, Kreter A, Autissier E, Barthe MF, Desgardin P, Schwarz-Selinger T, Burwitz V, Feuillastre S, Garcia-Argote S, Pieters G, Rousseau B, Ialovega M, Bisson R, Ghiorghiu F, Corr C, Thompson M, Doerner R, Markelj S, Yamada H, Yoshida N, Grisolia C. Tritium retention in W plasma-facing materials: Impact of the material structure and helium irradiation. Nuclear Materials and Energy 2019. [DOI: 10.1016/j.nme.2019.03.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
38
|
Snee M, Cheeseman S, Thompson M, Riaz M, Lacoin L, Sopwith W, Chaib C, Daumont M, Penrod J, O’Donnell J, Hall G. Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz070.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Nisbet S, Mahalingam H, Gfeller CF, Biggs E, Lucas S, Thompson M, Cargill MR, Moore D, Bielfeldt S. Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies. Int J Cosmet Sci 2019; 41:1-11. [PMID: 30414275 PMCID: PMC6849859 DOI: 10.1111/ics.12499] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Accepted: 11/05/2018] [Indexed: 12/21/2022]
Abstract
Objective Two studies were designed to evaluate the potential cosmetic benefit of a biomimetic, niacinamide‐containing moisturizing cream for the first time in humans. Methods In both studies, healthy women were randomized to use two treatments, one for the left side of the body and one for the right, from three options: the test cream, a positive control or no treatment (use of standard cleanser only). Treatments were applied twice daily for 4 weeks to the face and forearms (Study 1) or the face only (Study 2). Instrumental and clinical skin assessments were performed by trained technicians. Study 1 involved tape stripping and a 5‐day no‐treatment (‘regression’) period at the end of the 4 weeks. Independent lay graders were asked to grade the skin texture of subjects in Study 2 from high‐resolution photographs. Results In Study 1 (n = 66), the test cream significantly decreased the transepidermal water loss (TEWL) values on the forearm, and in the cheek area of the face, relative to baseline and compared to no treatment, and increased skin Corneometer values. The improvements were partially retained during a subsequent 5‐day period of no treatment. Increases in TEWL values on skin subjected to tape stripping were significantly lower after 4 weeks of using the test cream compared to no treatment. In Study 2 (n = 72 subjects with visible signs of ageing), there was a favourable trend in the change from baseline of a skin roughness parameter, Ra, for the test cream compared to no treatment. There were statistically significant improvements in the Fitzpatrick wrinkle score compared to no treatment, decreases in TEWL and increased Corneometer values and Cutometer values (R5 elasticity parameter). Grading of high‐resolution images failed to detect the improvements in skin texture (defined as pores, smoothness and unevenness) for the test cream vs. no treatment. No treatment‐related serious or severe adverse events were reported. Conclusion Twice daily application of the test cream over 4 weeks had beneficial effects on skin barrier function, moisturization, wrinkle dimensions and elasticity compared to no treatment. These studies provide proof‐of‐concept evidence and highlight the cosmetic benefit of the biomimetic lamellar cream formulation. Study registration: NCT03216265, NCT03180645.
Collapse
Affiliation(s)
- S Nisbet
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - H Mahalingam
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, 184 Liberty Corner Road, Warren, NJ 07059, U.S.A
| | - C F Gfeller
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - E Biggs
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - S Lucas
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - M Thompson
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - M R Cargill
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - D Moore
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - S Bielfeldt
- proDERM Institute for Applied Dermatological Research, Kiebitzweg 2, Schenefeld/Hamburg, 22869, Germany
| |
Collapse
|
40
|
Twelves C, Cheeseman S, Thompson M, Riaz M, Perren T, Ahat-Donker N, Sopwith W, Myland M, Lee A, Turner S, Hall G. Abstract P4-13-14: “Real world” characteristics, treatment patterns and outcomes of patients with hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-) metastatic breast cancer (MBC). Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-13-14] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
OBJECTIVES: Outcomes for patients with MBC vary according to disease phenotype and treatment history. We present UK real-world patient characteristics, treatment patterns and outcomes for patients with HR+/HER2- BC treated at a single cancer center.
METHODS: A retrospective review of health records including coded data, unstructured text and clinical review of patients treated from January 2012 to March 2018 identified females ≥ 18 years with metastatic or locally advanced HR+/HER2- BC. Those enrolled in clinical trials, with operable local recurrence as only disease site, incomplete treatment records or significant secondary malignancy were excluded. Patient characteristics, systemic, local (radiotherapy/surgery) and supportive treatments, health care resource use (HRU) and overall survival (OS) are presented. OS was estimated using the Kaplan-Meier method, censoring patients alive at study end.
RESULTS: 253 patients meeting study inclusion criteria were identified (median age 67, IQR 56,76; 84% post-menopausal), of whom 47 (19%) had locally advanced disease (T4 and/or N3), 75 (30%) had MBC at initial presentation and 131 (52%) had metastatic disease at first recurrence. Among patients with MBC at initial presentation, all received systemic treatment following diagnosis, including chemotherapy (35%), endocrine (93%) and targeted therapy (i.e. everolimus 7%). Among those recurring with MBC, 97% subsequently received systemic treatment, including chemotherapy (50%), endocrine (93%) and targeted therapy (27%). For patients recurring with MBC, the most common first line therapies (LoT) were letrozole (20%), exemestane (single agent, 15%), anastrozole (14%), everolimus (with exemestane, 11%) and paclitaxel (9%). For patients diagnosed with MBC, the most common first LoT were letrozole (47%), anastrozole (23%) and EC (11%). At second LoT, the most commonly used regimen for patients recurring with MBC was fulvestrant (13%) and for patients with MBC at initial diagnosis, it was exemestane (19%). Median OS for patients recurring with MBC was estimated to be 2.11 years (IQR 1.80,3.05), compared with 2.65 years (IQR 2.24,2.95) for those with metastatic disease at initial diagnosis. Median available follow-up time for the whole cohort was 2.85 years (IQR 1.42,4.82).
CONCLUSIONS: Patients with overt metastatic disease at presentation comprise a substantial proportion of those treated for MBC. With the follow-up time available, estimated median OS for patients with metastatic disease at initial presentation appears somewhat better than for those recurring with metastatic disease. Real world analysis demonstrates diverse treatment pathways for patients with HR+, HER2- MBC, reflecting the individualized care they receive.
Citation Format: Twelves C, Cheeseman S, Thompson M, Riaz M, Perren T, Ahat-Donker N, Sopwith W, Myland M, Lee A, Turner S, Hall G. “Real world” characteristics, treatment patterns and outcomes of patients with hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-) metastatic breast cancer (MBC) [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-13-14.
Collapse
Affiliation(s)
- C Twelves
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - S Cheeseman
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - M Thompson
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - M Riaz
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - T Perren
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - N Ahat-Donker
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - W Sopwith
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - M Myland
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - A Lee
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - S Turner
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| | - G Hall
- Leeds Cancer Centre, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom; IQVIA, London, United Kingdom; Novartis Pharmaceuticals UK Ltd, Surrey, United Kingdom; Novartis Pharmaceuticals Corporation, East Hanover
| |
Collapse
|
41
|
Snee M, Cheeseman S, Thompson M, Lacoin L, Sopwith W, Chaib C, Daumont M, Penrod J, O'Donnell J, Hall G. P2.01-91 Treatment Patterns in Patients with Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1145] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
42
|
Deng BH, Rouillard M, Feng P, Beall M, Armstrong S, Castellanos J, Kinley J, Leinweber HK, Ottaviano A, Settles G, Snitchler G, Wells J, Ziaei S, Thompson M. Development of a three-wave far-infrared laser interferometry and polarimetry diagnostic system for the C-2W field-reversed configuration plasmas. Rev Sci Instrum 2018; 89:10B109. [PMID: 30399682 DOI: 10.1063/1.5036977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Accepted: 06/27/2018] [Indexed: 06/08/2023]
Abstract
Great advancements in modern field-reversed configuration (FRC) experiments motivated the development of a 14-chord three-wave far infrared (FIR) laser interferometry and polarimetry diagnostic system, which can provide simultaneous high temporal resolution measurements of density and Faraday rotation profiles with high accuracy. The unique challenges facing FIR diagnostics in high beta FRC plasmas are the extremely small (<0.5°) Faraday rotation angles, and severe laser beam refraction effects due to high density gradient and choice of long wavelength. The diagnostic system design and development are described with methods to overcome the challenges, and initial experimental data are also presented.
Collapse
Affiliation(s)
- B H Deng
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - M Rouillard
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - P Feng
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - M Beall
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - S Armstrong
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - J Castellanos
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - J Kinley
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - H K Leinweber
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - A Ottaviano
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - G Settles
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - G Snitchler
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - J Wells
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - S Ziaei
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - M Thompson
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| |
Collapse
|
43
|
Schmitz L, Deng B, Thompson M, Gota H, Lau C, Fulton DP, Lin Z, Tajima T, Binderbauer M. Combination Doppler backscattering/cross-polarization scattering diagnostic for the C-2W field-reversed configuration. Rev Sci Instrum 2018; 89:10H116. [PMID: 30399746 DOI: 10.1063/1.5038914] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Accepted: 06/20/2018] [Indexed: 06/08/2023]
Abstract
A versatile combination Doppler backscattering and Cross-Polarization Scattering (CPS) diagnostic for the C-2W beam-driven field-reversed configuration is described. This system is capable of measuring density fluctuations and perpendicular magnetic field fluctuations across a wide wavenumber range (2.5 ≤ k θ ρ s ≤ 50), with typical resolution Δk θ/k θ ≤ 0.4-0.8. Four tunable frequencies (26 GHz ≤ f ≤ 60 GHz corresponding to plasma cut-off densities 0.8 × 1019 ≤ n e ≤ 4.4 × 1019 m-3) are launched via quasi-optical beam combiners/polarizers and an adjustable parabolic focusing mirror selecting the beam incidence angle. GENRAY ray tracing shows that the incident O-mode and backscattered CPS X-mode beam trajectories for C-2W plasma parameters nearly overlap, allowing simultaneous detection of ñ and B̃ r or B̃ θ from essentially the same scattering volume.
Collapse
Affiliation(s)
- L Schmitz
- Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, California 90095, USA
| | - B Deng
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - M Thompson
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - H Gota
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - C Lau
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - D P Fulton
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - Z Lin
- Department of Physics and Astronomy, University of California Irvine, Irvine, California 92697, USA
| | - T Tajima
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| | - M Binderbauer
- TAE Technologies, Inc., Foothill Ranch, California 92610, USA
| |
Collapse
|
44
|
Pasternak M, Thompson M, Rosenwaks Z, Spandorfer S. Embryo morphology on day 3 of embryogenesis is predictive of pregnancy and live birth rates in euploid embryos; analysis of 1112 euploid embryo transfers. Fertil Steril 2018. [DOI: 10.1016/j.fertnstert.2018.07.977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
45
|
Hagins D, Orkin C, Daar ES, Mills A, Brinson C, DeJesus E, Post FA, Morales-Ramirez J, Thompson M, Osiyemi O, Rashbaum B, Stellbrink HJ, Martorell C, Liu H, Liu YP, Porter D, Collins SE, SenGupta D, Das M. Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96-week results from two randomized clinical trials. HIV Med 2018; 19:724-733. [PMID: 30101539 PMCID: PMC6221083 DOI: 10.1111/hiv.12664] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/18/2018] [Indexed: 01/23/2023]
Abstract
Objectives The single‐tablet regimen rilpivirine, emtricitabine and tenofovir alafenamide (RPV/FTC/TAF) for treatment of HIV‐1‐infected adults was approved based on bioequivalence. We assessed the clinical efficacy, safety and tolerability of switching to RPV/FTC/TAF from either RPV/FTC/tenofovir disoproxil fumarate (TDF) or efavirenz (EFV)/FTC/TDF. Methods We conducted two distinct randomized, double‐blind, active‐controlled, noninferiority trials in participants taking RPV/FTC/TDF (Study 1216) and EFV/FTC/TDF (Study 1160). Each study randomized virologically suppressed (HIV‐1 RNA < 50 copies/mL) adults (1:1) to switch to RPV/FTC/TAF or continue their current regimen for 96 weeks. We evaluated efficacy as the proportion with HIV‐1 RNA < 50 copies/mL using the Food and Drug Administration snapshot algorithm and prespecified bone and renal endpoints at week 96. Results We randomized and treated 630 participants in Study 1216 (RPV/FTC/TAF, n = 316; RPV/FTC/TDF, n = 314) and 875 in Study 1160 (RPV/FTC/TAF, n = 438; EFV/FTC/TDF, n = 437). In both studies, the efficacy of switching to RPV/FTC/TAF was noninferior to that of continuing baseline therapy at week 96, with respective percentages of patients with HIV RNA < 50 copies/mL being 89.2% versus 88.5% in Study 1216 [difference 0.7%; 95% confidence interval (CI) −4.3 to +5.8%] and 85.2% versus 85.1% in Study 1160 (difference 0%; 95% CI −4.8 to +4.8%). No participant on RPV/FTC/TAF developed treatment‐emergent resistance versus two on EFV/FTC/TDF and one on RPV/FTC/TDF. Compared with continuing baseline therapy, significant improvements in bone mineral density and renal tubular markers were observed in the RPV/FTC/TAF groups (P < 0.001). Conclusions Switching to RPV/FTC/TAF from RPV/FTC/TDF or EFV/FTC/TDF was safe and effective and improved bone mineral density and renal biomarkers up to 96 weeks with no cases of treatment‐emergent resistance.
Collapse
Affiliation(s)
- D Hagins
- Georgia Department of Public Health, Chatham Care Center, Savannah, GA, USA
| | - C Orkin
- Grahame Hayton Unit, Royal London Hospital and Queen Mary University, London, UK
| | - E S Daar
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA
| | - A Mills
- Mills Clinical Research, Los Angeles, CA, USA
| | - C Brinson
- Central Texas Clinical Research, Austin, TX, USA
| | - E DeJesus
- Orlando Immunology Center, Orlando, FL, USA
| | - F A Post
- King's College Hospital, London, UK
| | | | - M Thompson
- AIDS Research Consortium of Atlanta, Atlanta, GA, USA
| | - O Osiyemi
- Triple O Research Institute PA, West Palm Beach, FL, USA
| | - B Rashbaum
- Capital Medical Associates, Washington, DC, USA
| | | | - C Martorell
- The Research Institute, Springfield, MA, USA
| | - H Liu
- Gilead Sciences Inc, Foster City, CA, USA
| | - Y-P Liu
- Gilead Sciences Inc, Foster City, CA, USA
| | - D Porter
- Gilead Sciences Inc, Foster City, CA, USA
| | | | - D SenGupta
- Gilead Sciences Inc, Foster City, CA, USA
| | - M Das
- Gilead Sciences Inc, Foster City, CA, USA
| |
Collapse
|
46
|
Costello BT, Voskoboinik A, Qadri AM, La Gerche AM, Hare J, Rudman M, Thompson M, Kistler P, Taylor AJ. P875Atrial stasis measured by cardiac magnetic resonance 4D flow particle tracing is present during sinus rhythm in patients with paroxysmal atrial fibrillation and is associated with higher stroke risk. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- B T Costello
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | - A Voskoboinik
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | - A M Qadri
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | - A M La Gerche
- Baker IDI Heart and Diabetes Institute, Melbourne, Australia
| | - J Hare
- The Alfred Hospital, Melbourne, Australia
| | - M Rudman
- Monash University, Melbourne, Australia
| | | | - P Kistler
- The Alfred Hospital, Melbourne, Australia
| | - A J Taylor
- The Alfred Hospital, Melbourne, Australia
| | | |
Collapse
|
47
|
Chang PD, Kuoy E, Grinband J, Weinberg BD, Thompson M, Homo R, Chen J, Abcede H, Shafie M, Sugrue L, Filippi CG, Su MY, Yu W, Hess C, Chow D. Hybrid 3D/2D Convolutional Neural Network for Hemorrhage Evaluation on Head CT. AJNR Am J Neuroradiol 2018; 39:1609-1616. [PMID: 30049723 DOI: 10.3174/ajnr.a5742] [Citation(s) in RCA: 122] [Impact Index Per Article: 20.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2018] [Accepted: 06/06/2018] [Indexed: 01/28/2023]
Abstract
BACKGROUND AND PURPOSE Convolutional neural networks are a powerful technology for image recognition. This study evaluates a convolutional neural network optimized for the detection and quantification of intraparenchymal, epidural/subdural, and subarachnoid hemorrhages on noncontrast CT. MATERIALS AND METHODS This study was performed in 2 phases. First, a training cohort of all NCCTs acquired at a single institution between January 1, 2017, and July 31, 2017, was used to develop and cross-validate a custom hybrid 3D/2D mask ROI-based convolutional neural network architecture for hemorrhage evaluation. Second, the trained network was applied prospectively to all NCCTs ordered from the emergency department between February 1, 2018, and February 28, 2018, in an automated inference pipeline. Hemorrhage-detection accuracy, area under the curve, sensitivity, specificity, positive predictive value, and negative predictive value were assessed for full and balanced datasets and were further stratified by hemorrhage type and size. Quantification was assessed by the Dice score coefficient and the Pearson correlation. RESULTS A 10,159-examination training cohort (512,598 images; 901/8.1% hemorrhages) and an 862-examination test cohort (23,668 images; 82/12% hemorrhages) were used in this study. Accuracy, area under the curve, sensitivity, specificity, positive predictive value, and negative-predictive value for hemorrhage detection were 0.975, 0.983, 0.971, 0.975, 0.793, and 0.997 on training cohort cross-validation and 0.970, 0.981, 0.951, 0.973, 0.829, and 0.993 for the prospective test set. Dice scores for intraparenchymal hemorrhage, epidural/subdural hemorrhage, and SAH were 0.931, 0.863, and 0.772, respectively. CONCLUSIONS A customized deep learning tool is accurate in the detection and quantification of hemorrhage on NCCT. Demonstrated high performance on prospective NCCTs ordered from the emergency department suggests the clinical viability of the proposed deep learning tool.
Collapse
Affiliation(s)
- P D Chang
- From the Departments of Radiology (P.D.C., E.K., M.T., R.H., M.-Y.S., D.C.).,Departments of Radiology (P.D.C., L.S., C.H.), University of California, San Francisco, California
| | - E Kuoy
- From the Departments of Radiology (P.D.C., E.K., M.T., R.H., M.-Y.S., D.C.)
| | - J Grinband
- Department of Radiology (J.G.), Columbia University, New York, New York
| | - B D Weinberg
- Department of Radiology (B.D.W.), Emory University School of Medicine, Atlanta, Georgia
| | - M Thompson
- From the Departments of Radiology (P.D.C., E.K., M.T., R.H., M.-Y.S., D.C.)
| | - R Homo
- From the Departments of Radiology (P.D.C., E.K., M.T., R.H., M.-Y.S., D.C.)
| | | | - H Abcede
- Neurology (H.A., M.S., W.Y.), University of California Irvine
| | - M Shafie
- Neurology (H.A., M.S., W.Y.), University of California Irvine
| | - L Sugrue
- Departments of Radiology (P.D.C., L.S., C.H.), University of California, San Francisco, California
| | - C G Filippi
- Department of Radiology (C.G.F.), North Shore University Hospital, Long Island, New York
| | - M-Y Su
- From the Departments of Radiology (P.D.C., E.K., M.T., R.H., M.-Y.S., D.C.)
| | - W Yu
- Neurology (H.A., M.S., W.Y.), University of California Irvine
| | - C Hess
- Departments of Radiology (P.D.C., L.S., C.H.), University of California, San Francisco, California
| | - D Chow
- From the Departments of Radiology (P.D.C., E.K., M.T., R.H., M.-Y.S., D.C.)
| |
Collapse
|
48
|
Cholewiak D, Clark CW, Ponirakis D, Frankel A, Hatch LT, Risch D, Stanistreet JE, Thompson M, Vu E, Van Parijs SM. Communicating amidst the noise: modeling the aggregate influence of ambient and vessel noise on baleen whale communication space in a national marine sanctuary. ENDANGER SPECIES RES 2018. [DOI: 10.3354/esr00875] [Citation(s) in RCA: 48] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
49
|
Grima M, Boufi M, Law M, Jackson D, Stenson K, Patterson B, Loftus I, Thompson M, Karthikesalingam A, Holt P. The Implications of Non-compliance to Endovascular Aneurysm Repair Surveillance: A Systematic Review and Meta-analysis. J Vasc Surg 2018. [DOI: 10.1016/j.jvs.2018.03.402] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
50
|
Nazarov A, Fikretoglu D, Liu A, Thompson M, Zamorski MA. Greater prevalence of post-traumatic stress disorder and depression in deployed Canadian Armed Forces personnel at risk for moral injury. Acta Psychiatr Scand 2018; 137:342-354. [PMID: 29504125 DOI: 10.1111/acps.12866] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/01/2018] [Indexed: 12/31/2022]
Abstract
BACKGROUND A link between moral injury (i.e., the psychological distress caused by perceived moral transgressions) and adverse mental health outcomes (AMHO) has been recently proposed. However, the prevalence of exposure to morally injurious events and the associated risk of experiencing AMHO remains understudied. METHOD The impact of exposure to potentially morally injurious experiences (PMIEs) was explored in relation to past-year PTSD and MDD, using the 2013 Canadian Armed Forces Mental Health Survey dataset of Afghanistan mission deployed regular force and reserve personnel. A series of logistic regressions were conducted, controlling for relevant sociodemographic, military, deployment, and trauma-related variables. RESULTS Over half of the deployed personnel endorsed at least one PMIE. Several demographic and military variables were associated with exposure to PMIEs. Those exposed to PMIEs demonstrated a greater likelihood of having past-year PTSD and MDD; feeling responsible for the death of Canadian or ally personnel demonstrated the strongest association with PTSD and MDD. Mental health training was not a moderator for PMIE exposure and AMHO. CONCLUSIONS Exposure to PMIEs during deployments is common and represents an independent risk factor for past-year PTSD and MDD. Improved training that targets moral-ethical dilemmas and treatment interventions that address moral injury expressions is warranted.
Collapse
Affiliation(s)
- A Nazarov
- Department of National Defence, Defence Research and Development Canada, Toronto, ON, Canada.,Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, ON, Canada
| | - D Fikretoglu
- Department of National Defence, Defence Research and Development Canada, Toronto, ON, Canada.,Douglas Mental Health University Institute, McGill University, Ottawa, ON, Canada
| | - A Liu
- Douglas Mental Health University Institute, McGill University, Ottawa, ON, Canada
| | - M Thompson
- Department of National Defence, Defence Research and Development Canada, Toronto, ON, Canada
| | - M A Zamorski
- Directorate of Mental Health, Canadian Forces Health Services Group, Ottawa, ON, Canada.,Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada
| |
Collapse
|